Clin Endosc.  2024 Jan;57(1):51-52. 10.5946/ce.2023.188.

Clinicians should be aware of proton pump inhibitor–related changes in the gastric mucosa

• Kim GH

• KMID: 2551190
• DOI: http://doi.org/10.5946/ce.2023.188

Reference

1. Nocon M, Labenz J, Jaspersen D, et al. Long-term treatment of patients with gastro-oesophageal reflux disease in routine care: results from the ProGERD study. Aliment Pharmacol Ther. 2007; 25:715–722.

2. Joel A, Konjengbam A, Viswanath Y, et al. Endoscopic radiofrequency Stretta therapy reduces proton pump inhibitor dependency and the need for anti-reflux surgery for refractory gastroesophageal reflux disease. Clin Endosc. 2024; 57:58–64.

3. Welsch L, May A, Blasberg T, et al. Bile acid sequestrants in poor healing after endoscopic therapy of Barrett's esophagus. Clin Endosc. 2023; 56:194–202.

4. Kim GH. Proton pump inhibitor-related gastric mucosal changes. Gut Liver. 2021; 15:646–652.

5. Haruma K, Kato M, Inoue K, et al. Kyoto classification of gastritis. 2nd ed. Tokyo: Nihon Medical Center;2019.

6. Hatano Y, Haruma K, Kamada T, et al. Factors associated with gastric black spot, white flat elevated mucosa, and cobblestone-like mucosa: a cross-sectional study. Digestion. 2018; 98:185–193.

7. Majima K, Muraki Y, Shimamoto T. Multiple white and flat elevated lesions observed in the stomach: a prospective study of clinical characteristics and risk factors. Intern Med. 2018; 57:2613–2619.

8. Hasegawa R, Yao K, Kanemitsu T, et al. Association between occurrence of multiple white and flat elevated gastric lesions and oral proton pump inhibitor intake. Clin Endosc. 2024; 57:65–72.

9. Uedo N, Yamaoka R, Yao K. Multiple white flat lesions in the gastric corpus are not intestinal metaplasia. Endoscopy. 2017; 49:615–616.